Polypharmacy and anticholinergic burden are common but not independently associated with outcomes after emergency laparotomy in older adults

Anticholinergic burden (ACB) is an accumulative effect of medications with individual anticholinergic properties. ACB arising from polypharmacy is common in older adults and has been linked to poorer outcomes in a variety of clinical contexts. With more older patients undergoing surgery, there is greater exposure to higher risk individuals with polypharmacy and increased ACB, although the significance of these postoperatively is unknown. The purpose of the study was to determine the frequency of polypharmacy and accompanying ACB in older patients undergoing laparotomy and to investigate their effect on outcomes. An ambispective, observational cohort study was conducted across two UK hospitals and included patients aged ≥ 65 undergoing emergency laparotomy, as per National Emergency Laparotomy Audit (NELA) criteria, over a 2-year period. Patients with polypharmacy (≥ 5 drugs) or high ACB (ACB score ≥ 3) were identified. Primary outcome was mortality up to 1 year and secondary outcomes included postoperative complications, functional and cognitive decline, intensive care unit (ICU) admission, length of hospital stay and readmission within 30-days. A total of 144 patients were included (median age 76, 54% female) of which 42% had polypharmacy and 17% had high ACB. There was no significant difference in mortality up to 1 year following surgery between those with or without polypharmacy, nor those with or without significant ACB. Patients with polypharmacy had longer hospital stays (15 vs. 12 days, p = 0.025). There were no significant differences demonstrated for other secondary outcomes. Polypharmacy and high ACB are common in older adults undergoing emergency laparotomy but neither appeared to influence adverse outcomes apart from increased length of hospitalisation. Polypharmacy and ACB may simply be surrogate markers for age, frailty and comorbidity burden. The relationship should be further explored in larger, well-designed studies.

Authors

Institutions

Publication Details

Journal
Langenbeck s Archives of Surgery
Published
2026-04-21
DOI
https://doi.org/10.1007/s00423-026-04060-z
Primary Topic
Cardiac, Anesthesia and Surgical Outcomes
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Polypharmacy and anticholinergic burden are common but not independently associated with outcomes after emergency laparotomy in older adults

Vadir Baktash, Amit Mandal, Randeep S. Heer, Sharmistha Gupta et al.
Langenbeck s Archives of Surgery
Cardiac, Anesthesia and Surgical Outcomes
article

Polypharmacy and anticholinergic burden are common but not independently associated with outcomes after emergency laparotomy in older adults

Vadir Baktash, Amit Mandal, Randeep S. Heer, Sharmistha Gupta, Hannah Binns, Henry D. De’Ath, Fahad Javed, Constantinos G. Missouris, Rebecca Atkins, Ravi Vissapragada
article en

Abstract

Anticholinergic burden (ACB) is an accumulative effect of medications with individual anticholinergic properties. ACB arising from polypharmacy is common in older adults and has been linked to poorer outcomes in a variety of clinical contexts. With more older patients undergoing surgery, there is greater exposure to higher risk individuals with polypharmacy and increased ACB, although the significance of these postoperatively is unknown. The purpose of the study was to determine the frequency of polypharmacy and accompanying ACB in older patients undergoing laparotomy and to investigate their effect on outcomes. An ambispective, observational cohort study was conducted across two UK hospitals and included patients aged ≥ 65 undergoing emergency laparotomy, as per National Emergency Laparotomy Audit (NELA) criteria, over a 2-year period. Patients with polypharmacy (≥ 5 drugs) or high ACB (ACB score ≥ 3) were identified. Primary outcome was mortality up to 1 year and secondary outcomes included postoperative complications, functional and cognitive decline, intensive care unit (ICU) admission, length of hospital stay and readmission within 30-days. A total of 144 patients were included (median age 76, 54% female) of which 42% had polypharmacy and 17% had high ACB. There was no significant difference in mortality up to 1 year following surgery between those with or without polypharmacy, nor those with or without significant ACB. Patients with polypharmacy had longer hospital stays (15 vs. 12 days, p = 0.025). There were no significant differences demonstrated for other secondary outcomes. Polypharmacy and high ACB are common in older adults undergoing emergency laparotomy but neither appeared to influence adverse outcomes apart from increased length of hospitalisation. Polypharmacy and ACB may simply be surrogate markers for age, frailty and comorbidity burden. The relationship should be further explored in larger, well-designed studies.

Langenbeck s Archives of Surgery
Flinders University (AU), University of Nicosia (CY), Wexham Park Hospital (GB), Frimley Park Hospital (GB)
Flinders University
No poverty
Openalex Percentile: Top 12%
Cardiac, Anesthesia and Surgical Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.